• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Kidney cancer: Characterizing late recurrence of renal cell carcinoma.

作者信息

Ficarra Vincenzo, Novara Giacomo

机构信息

Department of Experimental and Clinical Medical Sciences, Urology Unit, University of Udine, Piazzale Santa Maria della Misericordia 15, Clinica di Urologia, Padiglione 5, 33100 Udine, Italy.

出版信息

Nat Rev Urol. 2013 Dec;10(12):687-9. doi: 10.1038/nrurol.2013.239. Epub 2013 Oct 29.

DOI:10.1038/nrurol.2013.239
PMID:24166346
Abstract
摘要

相似文献

1
Kidney cancer: Characterizing late recurrence of renal cell carcinoma.肾癌：肾细胞癌晚期复发的特征分析
Nat Rev Urol. 2013 Dec;10(12):687-9. doi: 10.1038/nrurol.2013.239. Epub 2013 Oct 29.
2
[Staging and follow-up of renal cell carcinoma].[肾细胞癌的分期与随访]
J Radiol. 2002 Jun;83(6 Pt 2):805-22, discussion 823-4.
3
[When is aftercare useful in renal cell cancer?].[肾癌的术后护理何时有用？]
Urologe A. 2005 Sep;44(9):1018, 1020-3. doi: 10.1007/s00120-005-0880-y.
4
NCCN clinical practice guidelines in oncology: kidney cancer.美国国立综合癌症网络（NCCN）肿瘤学临床实践指南：肾癌
J Natl Compr Canc Netw. 2009 Jun;7(6):618-30. doi: 10.6004/jnccn.2009.0043.
5
Adjuvant therapy in renal cell carcinoma: is resection still solely enough?肾细胞癌的辅助治疗：单纯手术切除是否仍然足够？
Future Oncol. 2021 Feb;17(6):633-636. doi: 10.2217/fon-2020-0982. Epub 2020 Dec 11.
6
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.肾细胞癌：欧洲肿瘤内科学会临床实践诊断、治疗及随访指南
Ann Oncol. 2014 Sep;25 Suppl 3:iii49-56. doi: 10.1093/annonc/mdu259.
7
Case for nephron-sparing surgery in managing renal cell carcinoma.保留肾单位手术治疗肾细胞癌的病例分析
Semin Urol. 1993 May;11(2):104-11.
8
Kidney cancer: Recurrence in renal cell carcinoma: the work is not done.肾癌：肾细胞癌的复发：工作尚未完成。
Nat Rev Urol. 2016 May;13(5):246-7. doi: 10.1038/nrurol.2016.57. Epub 2016 Mar 31.
9
Renal-cell carcinoma: vaccination and risk of tumour progression.肾细胞癌：疫苗接种与肿瘤进展风险
Lancet. 2004 May 8;363(9420):1557; author reply 1557. doi: 10.1016/S0140-6736(04)16169-2.
10
Pediatric renal tumors.小儿肾肿瘤
Semin Surg Oncol. 1999 Mar;16(2):105-20. doi: 10.1002/(sici)1098-2388(199903)16:2<105::aid-ssu4>3.0.co;2-t.

引用本文的文献

1
Novel model of pyroptosis-related molecular signatures for prognosis prediction of clear cell renal cell carcinoma patients.新型细胞焦亡相关分子特征模型用于预测透明细胞肾细胞癌患者的预后。
Int J Med Sci. 2024 Jan 1;21(3):496-507. doi: 10.7150/ijms.88301. eCollection 2024.
2
CD56 polysialylation promotes the tumorigenesis and progression via the Hedgehog and Wnt/β-catenin signaling pathways in clear cell renal cell carcinoma.CD56多唾液酸化通过刺猬信号通路和Wnt/β-连环蛋白信号通路促进透明细胞肾细胞癌的肿瘤发生和进展。
Cancer Cell Int. 2023 Dec 12;23(1):319. doi: 10.1186/s12935-023-03165-5.
3
Metastatic Clear Cell Renal Cell Carcinoma Presenting as Acute Appendicitis.

本文引用的文献

1
Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy.靶向治疗时代肾细胞癌晚期复发患者的生存结局和治疗反应。
Eur Urol. 2014 Jun;65(6):1086-92. doi: 10.1016/j.eururo.2013.07.031. Epub 2013 Jul 30.
2
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).复发时间是复发性肾细胞癌患者复发后癌症特异性生存的重要预测指标——来自综合多中心数据库（CORONA/SATURN-项目）的结果。
BJU Int. 2013 Nov;112(7):909-16. doi: 10.1111/bju.12246. Epub 2013 Jul 25.
3
以急性阑尾炎表现的转移性透明细胞肾细胞癌
Cureus. 2023 Aug 26;15(8):e44155. doi: 10.7759/cureus.44155. eCollection 2023 Aug.
4
Partial nephrectomy and positive surgical margin, oncologic outcomes and predictors: a 15-year single institution experience.部分肾切除术与手术切缘阳性、肿瘤学结局及预测因素：一项单机构15年的经验
Cent European J Urol. 2021;74(4):516-522. doi: 10.5173/ceju.2021.0191. Epub 2021 Dec 6.
5
TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination.TRIM47通过泛素化降解P53促进肾细胞癌的恶性进展。
Cancer Cell Int. 2021 Feb 23;21(1):129. doi: 10.1186/s12935-021-01831-0.
6
Renal Cell Carcinoma Diagnosis After Initial Detection on Screening Mammogram.在筛查乳房X线摄影初次检测后诊断为肾细胞癌。
Cureus. 2020 Sep 13;12(9):e10428. doi: 10.7759/cureus.10428.
7
Is active surveillance an option for metachronous metastatic renal cell carcinoma?主动监测是否适用于异时性转移性肾细胞癌？
Ann Transl Med. 2019 Mar;7(5):84. doi: 10.21037/atm.2019.01.08.
8
Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.生物信息学分析确定 CEP55 在肾透明细胞癌中的诊断和预后价值。
Mol Med Rep. 2019 May;19(5):3485-3496. doi: 10.3892/mmr.2019.10042. Epub 2019 Mar 15.
9
Surgical Management of Local Recurrences of Renal Cell Carcinoma.肾细胞癌局部复发的外科治疗
Surg Res Pract. 2016;2016:2394942. doi: 10.1155/2016/2394942. Epub 2016 Jan 26.
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
肾细胞癌肾切除术后 5 年以上复发相关特征：基于大型多中心数据库（CORONA/SATURN 项目）开发和内部验证预测晚期复发的风险模型（PRELANE 评分）。
Eur Urol. 2013 Sep;64(3):472-7. doi: 10.1016/j.eururo.2012.06.030. Epub 2012 Jun 22.
4
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.肾细胞癌的预后因素和预测模型：当代综述。
Eur Urol. 2011 Oct;60(4):644-61. doi: 10.1016/j.eururo.2011.06.041. Epub 2011 Jun 30.
5
Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors.实质上皮性肾肿瘤的组织病理学定义的预后和治疗影响。
Eur Urol. 2010 Nov;58(5):655-68. doi: 10.1016/j.eururo.2010.08.001. Epub 2010 Aug 10.